Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 22 Aug 2022

Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease

in Renal Pharmacology

Wei Yu
Ting Wang
Feng Wu
Yiding Zhang
Jin Shang
Zhanzheng Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.931282

4,950 views
5 citations

Original Research

Published on 19 Aug 2022

Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease

in Renal Pharmacology

Jinfei Yang
Chenrui Li
Yan Liu
Yachun Han
Hao Zhao
Shilu Luo
Chanyue Zhao
Na Jiang
Ming Yang
Lin Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2022.832299

4,869 views
7 citations

Original Research

Published on 17 Aug 2022

Exploring the pathogenesis of diabetic kidney disease by microarray data analysis

in Renal Pharmacology

Haiyan Cao
Xiaosheng Rao
Junya Jia
Tiekun Yan
Dong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.932205

6,286 views
9 citations

Original Research

Published on 17 Aug 2022

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway

in Renal Pharmacology

Yan-Ni Wang
Hong-Jiao Liu
Li-Li Ren
Ping Suo
Liang Zou
Ya-Mei Zhang
Xiao-Yong Yu
Ying-Yong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.964370

4,628 views
27 citations

Original Research

Published on 16 Aug 2022

Comprehensive bibliometric analysis of sirtuins: Focus on sirt1 and kidney disease

in Renal Pharmacology

Tongtong Liu
Shujuan Mu
Liping Yang
Huimin Mao
Fang Ma
Yuyang Wang
Yongli Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.966786

5,706 views
2 citations

Original Research

Published on 16 Aug 2022

Total extract of Abelmoschus manihot L. alleviates uric acid-induced renal tubular epithelial injury via inhibition of caspase-8/caspase-3/NLRP3/GSDME signaling

in Renal Pharmacology

Zhihui Ding
Jing Zhao
Xufang Wang
Wei Li
Chong Chen
Chen Yong
Yiye Zhu
Fang Tian
Li Liu
Manshu Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.907980

6,222 views
13 citations

Original Research

Published on 16 Aug 2022

Sappanone a prevents diabetic kidney disease by inhibiting kidney inflammation and fibrosis via the NF-κB signaling pathway

in Renal Pharmacology

Zhe Wang
Zhida Chen
Xinyi Wang
Yepeng Hu
Jing Kong
Jiabin Lai
Tiekun Li
Bibi Hu
Yikai Zhang
Xianan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.953004

4,257 views
19 citations

Original Research

Published on 15 Aug 2022

Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice

in Renal Pharmacology

Binbin Cui
Xiying Hou
Mengjun Liu
Qing Li
Chao Yu
Shenglei Zhang
Yi Wang
Jun Wang
Shougang Zhuang
Feng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.829630

5,185 views
11 citations

Review

Published on 12 Aug 2022

TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

in Renal Pharmacology

Ye Zixin
Chen Lulu
Zeng Xiangchang
Fang Qing
Zheng Binjie
Luo Chunyang
Rao Tai
Ouyang Dongsheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.929262

10,693 views
57 citations

Review

Published on 11 Aug 2022

Molecular mechanisms and physiological functions of autophagy in kidney diseases

in Renal Pharmacology

Jingchao Yang
Longhui Yuan
Fei Liu
Lan Li
Jingping Liu
Younan Chen
Yanrong Lu
Yujia Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.974829

5,064 views
6 citations

Systematic Review

Published on 11 Aug 2022

Antioxidant and Anti-Inflammatory Properties of Hydroxyl Safflower Yellow a in Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials

in Renal Pharmacology

Shunlian Fu
Qian Zhou
Yang Gao
Yunjiao Yang
Huizhen Chen
Lijun Yuan
Zinan Li
Qiu Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.929169

4,484 views
14 citations

Review

Published on 09 Aug 2022

Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease

in Renal Pharmacology

Letian Yang
Bo Wang
Liang Ma
Ping Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.971032

9,269 views
33 citations

Review

Published on 08 Aug 2022

Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research

in Renal Pharmacology

Lirong Lin
En Tian
Jiangwen Ren
Zhifeng Wu
Junhui Deng
Jurong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.932739

4,510 views
1 citation

Original Research

Published on 03 Aug 2022

Activation of TRPC6 by AngⅡ Induces Podocyte Injury and Participates in Proteinuria of Nephrotic Syndrome

in Renal Pharmacology

Ye Feng
Manman Li
Yunlai Wang
Mo Yang
Gaoxiang Shi
Dengke Yin
Zihua Xuan
Fan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.915153

5,454 views
12 citations

Systematic Review

Published on 25 Jul 2022

Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis

in Renal Pharmacology

Jiarong Liu
Xiang Li
Tianlun Huang
Gaosi Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.917532

5,245 views
7 citations

Original Research

Published on 22 Jul 2022

Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation

in Renal Pharmacology

Jialu Li
Chao Yu
Fengchen Shen
Binbin Cui
Na Liu
Shougang Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.946192

3,939 views
12 citations